Press Resease

Therapeutic Respiratory Devices Market: by Product (Humidifiers, Inhalers, Ventilators, OSA Devices and Other Products); by End User (Homecare Settings, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Published Date: 02-Dec-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-5127 Status : Published

Global demand for therapeutic respiratory devices market was valued at approximately USD 12.46 billion in 2018, and is expected to generate revenue of around USD 22.15 billion by end of 2025, growing at a CAGR of around 8.6% between 2019 and 2025.

Description

The report covers forecast and analysis for the therapeutic respiratory devices market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the therapeutic respiratory devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the therapeutic respiratory devices market on a global as well as regional level.

According to the report, global demand for therapeutic respiratory devices market was valued at approximately USD 12.46 billion in 2018, and is expected to generate revenue of around USD 22.15 billion by end of 2025, growing at a CAGR of around 8.6% between 2019 and 2025.

In order to give the users of this report a comprehensive view on the therapeutic respiratory devices market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the therapeutic respiratory devices market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the therapeutic respiratory devices market on global and regional basis.

The study provides a crucial view on the therapeutic respiratory devices by segmenting the market based on product, end user and region. All the segments of therapeutic respiratory devices market have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.

Therapeutic respiratory devices are used for treating various chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), chronic bronchitis, asthma, sleep disorders etc. These devices assist in airway clearance thus improving pulmonary function. Different types of respiratory devices are available such as long-term respiratory devices for intensive care, emergency respiratory devices for rescue application, and mobile home respiratory devices.

The demand for therapeutic respiratory devices market is driven by increasing occurrence of various respiratory and pulmonary disorders such as asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD) along with increasing aging population across the globe. However lack of patient adherence to treatment and increasing cost burden of respiratory diseases may hamper the market growth over the forecast period. Untapped markets and technological advancements to improve therapeutic respiratory device efficiency and miniaturization to make them portable are factors that are expected to bring new growth avenues for major market players in the global therapeutic respiratory devices.

Based on product, global therapeutic respiratory devices market is bifurcated into humidifiers, inhalers, ventilators, obstructive sleep apnea (OSA) devices, and other products. OSA devices product segment accounted for almost two third of overall market share in 2018 due to growing prevalence of sleep disorders such as insomnia, sleep apnea, snoring etc. OSA devices segment is projected to retain its market share over the forecast period whereas ventilators are expected to register highest growth due to various factors such as increasing aging population, rise in number of surgeries, preterm births and respiratory diseases. OSA devices product segment is sub segmented into adaptive servo-ventilators, oxygen concentrators and PAP devices. Humidifiers are sub segmented into standalone humidifiers, built-in humidifiers, integrated humidifiers, passover humidifiers and heated humidifiers. Inhalers segment is sub segmented into metered dose inhalers (MDIs), nebulizers and dry powder inhalers (DPIs).

The end user segment is divided homecare settings, hospitals and other end users. Hospitals end user segment held largest market share due to ease of access, availability of advanced health facilities, equipment, skilled professionals and increasing number of patient pool. Homecare settings end user will see highest growth over the forecast period for therapeutic respiratory devices market due to increasing elderly population requiring home healthcare services.

North America dominated the global therapeutic respiratory devices market in 2018. Increasing prevalence of respiratory diseases, increasing aging population, increasing lifestyle changes such as smoking and environmental factors are expected to drive the market growth in North America. Europe was second leading regional market. Availability of developed infrastructure, increasing awareness and growing prevalence of respiratory diseases are major factors that boost market growth in this region. Latin America is estimated to witness moderate growth over the forecast period. Asia Pacific region is projected to see highest growth for therapeutic respiratory devices market in the coming years. Increasing aging population, increasing need for portable, easy to use home therapeutic devices for elderly care, lifestyle changes and environmental conditions are factors that fuel Asia Pacific therapeutic respiratory devices market growth. Middle East and Africa is projected see considerable growth in coming years.

Major players included in the report are Smiths Medical, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Teleflex Incorporated, Medtronic, ResMed, Koninklijke Philips N.V., Invacare Corporation, Inogen, Hill-Rom, Hamilton Medical, GE Healthcare, Fisher & Paykel Healthcare Limited, Compumedics Limited, Becton, Dickinson and Company, Breas Medical, and AirSep Corporation among others.

The report segment of global therapeutic respiratory devices market as follows:

Global Therapeutic Respiratory Devices Market: By Product

  • Obstructive Sleep Apnea (OSA) Devices
    • PAP Devices
    • Oxygen Concentrators
    • Adaptive Servo-ventilators
  • Ventilators
  • Inhalers
    • Nebulizers
    • Metered Dose Inhaler (MDI)
    • Dry Powder Inhaler (DPI)
  • Humidifiers
    • Heated Humidifiers
    • Passover Humidifiers
    • Integrated Humidifiers
    • Built-in Humidifiers
    • Standalone Humidifiers
  • Other Products

Global Therapeutic Respiratory Devices Market: By End User

  • Hospitals
  • Homecare Settings
  • Other End Users

Global Therapeutic Respiratory Devices Market: By Region

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Therapeutic Respiratory Devices Market, 2016 - 2025, (USD Million)
    • 2.2. Therapeutic Respiratory Devices Market: Snapshot
  • Chapter 3. Global Therapeutic Respiratory Devices Market - Industry Analysis
    • 3.1. Therapeutic Respiratory Devices Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Chronic Respiratory and Pulmonary Diseases
      • 3.2.2. Increasing Aging Population
    • 3.3. Restraints
      • 3.3.1. Lack of Patient Compliance
    • 3.4. Opportunity
      • 3.4.1. Emerging Markets
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by product segment
      • 3.6.2. Market attractiveness analysis by end user segment
      • 3.6.3. Market attractiveness analysis by regional segment
  • Chapter 4. Global Therapeutic Respiratory Devices Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global therapeutic respiratory devices market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Therapeutic Respiratory Devices Market - Product Segment Analysis
    • 5.1. Global therapeutic respiratory devices market overview: by product
      • 5.1.1. Global therapeutic respiratory devices market revenue share, by product, 2018 and 2025
    • 5.2. OSA Devices
      • 5.2.1. Global therapeutic respiratory devices market by OSA Devices, 2016-2025 (USD Million)
    • 5.3. Ventilators
      • 5.3.1. Global therapeutic respiratory devices market by Ventilators, 2016-2025 (USD Million)
    • 5.4. Inhalers
      • 5.4.1. Global therapeutic respiratory devices market by Inhalers, 2016-2025 (USD Million)
    • 5.5. Humidifiers
      • 5.5.1. Global therapeutic respiratory devices market by Humidifiers, 2016-2025 (USD Million)
    • 5.6. Other Products
      • 5.6.1. Global therapeutic respiratory devices market by Other Products, 2016-2025 (USD Million)
  • Chapter 6. Global Therapeutic Respiratory Devices Market - End User Segment Analysis
    • 6.1. Global therapeutic respiratory devices market overview: by end user
      • 6.1.1. Global therapeutic respiratory devices market revenue share, by end user, 2018 and 2025
    • 6.2. Hospitals
      • 6.2.1. Global therapeutic respiratory devices market by Hospitals, 2016-2025 (USD Million)
    • 6.3. Homecare Settings
      • 6.3.1. Global therapeutic respiratory devices market by Homecare Settings, 2016-2025 (USD Million)
    • 6.4. Other End Users
      • 6.4.1. Global therapeutic respiratory devices market by Other End Users, 2016-2025 (USD Million)
  • Chapter 7. Global Therapeutic Respiratory Devices Market - Regional Analysis
    • 7.1. Global therapeutic respiratory devices market overview: by region
      • 7.1.1. Global therapeutic respiratory devices market revenue share, by region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America therapeutic respiratory devices market, by country, 2016-2025 (USD Million)
      • 7.2.2. North America therapeutic respiratory devices market revenue, by product, 2016-2025 (USD Million)
      • 7.2.3. North America therapeutic respiratory devices market revenue, by end user, 2016-2025 (USD Million)
      • 7.2.4. The U.S.
        • 7.2.4.1. The U.S. therapeutic respiratory devices market revenue, by product, 2016-2025 (USD Million)
        • 7.2.4.2. The U.S. therapeutic respiratory devices market revenue, by end user, 2016-2025 (USD Million)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America therapeutic respiratory devices market revenue, by product, 2016-2025 (USD Million)
        • 7.2.5.2. Rest of North America therapeutic respiratory devices market revenue, by end user, 2016-2025 (USD Million)
    • 7.3. Europe
      • 7.3.1. Europe therapeutic respiratory devices market, by country, 2016-2025 (USD Million)
      • 7.3.2. Europe therapeutic respiratory devices market revenue, by product, 2016-2025 (USD Million)
      • 7.3.3. Europe therapeutic respiratory devices market revenue, by end user, 2016-2025 (USD Million)
      • 7.3.4. U.K.
        • 7.3.4.1. U.K. therapeutic respiratory devices market revenue, by product, 2016-2025 (USD Million)
        • 7.3.4.2. U.K. therapeutic respiratory devices market revenue, by end user, 2016-2025 (USD Million)
      • 7.3.5. France
        • 7.3.5.1. France therapeutic respiratory devices market revenue, by product, 2016-2025 (USD Million)
        • 7.3.5.2. France therapeutic respiratory devices market revenue, by end user, 2016-2025 (USD Million)
      • 7.3.6. Germany
        • 7.3.6.1. Germany therapeutic respiratory devices market revenue, by product, 2016-2025 (USD Million)
        • 7.3.6.2. Germany therapeutic respiratory devices market revenue, by end user, 2016-2025 (USD Million)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of Europe therapeutic respiratory devices market revenue, by product, 2016-2025 (USD Million)
        • 7.3.7.2. Rest of Europe therapeutic respiratory devices market revenue, by end user, 2016-2025 (USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific therapeutic respiratory devices market, by country, 2016-2025 (USD Million)
      • 7.4.2. Asia Pacific therapeutic respiratory devices market revenue, by product, 2016-2025 (USD Million)
      • 7.4.3. Asia Pacific therapeutic respiratory devices market revenue, by end user, 2016-2025 (USD Million)
      • 7.4.4. China
        • 7.4.4.1. China therapeutic respiratory devices market revenue, by product, 2016-2025 (USD Million)
        • 7.4.4.2. China therapeutic respiratory devices market revenue, by end user, 2016-2025 (USD Million)
      • 7.4.5. Japan
        • 7.4.5.1. Japan therapeutic respiratory devices market revenue, by product, 2016-2025 (USD Million)
        • 7.4.5.2. Japan therapeutic respiratory devices market revenue, by end user, 2016-2025 (USD Million)
      • 7.4.6. India
        • 7.4.6.1. India therapeutic respiratory devices market revenue, by product, 2016-2025 (USD Million)
        • 7.4.6.2. India therapeutic respiratory devices market revenue, by end user, 2016-2025 (USD Million)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific therapeutic respiratory devices market revenue, by product, 2016-2025 (USD Million)
        • 7.4.7.2. Rest of Asia Pacific therapeutic respiratory devices market revenue, by end user, 2016-2025 (USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America therapeutic respiratory devices market, by country, 2016-2025 (USD Million)
      • 7.5.2. Latin America therapeutic respiratory devices market revenue, by product, 2016-2025 (USD Million)
      • 7.5.3. Latin America therapeutic respiratory devices market revenue, by end user, 2016-2025 (USD Million)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil therapeutic respiratory devices market revenue, by product, 2016-2025 (USD Million)
        • 7.5.4.2. Brazil therapeutic respiratory devices market revenue, by end user, 2016-2025 (USD Million)
      • 7.5.5. Rest of Latin America
        • 7.5.5.1. Rest of Latin America therapeutic respiratory devices market revenue, by product, 2016-2025 (USD Million)
        • 7.5.5.2. Rest of Latin America therapeutic respiratory devices market revenue, by end user, 2016-2025 (USD Million)
    • 7.6. Middle East & Africa
      • 7.6.1. Middle East & Africa therapeutic respiratory devices market, 2016-2025 (USD Million)
      • 7.6.2. Middle East & Africa therapeutic respiratory devices market revenue, by product, 2016-2025 (USD Million)
      • 7.6.3. Middle East & Africa therapeutic respiratory devices market revenue, by end user, 2016-2025 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1. Hill-Rom
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Hamilton Medical
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. GE Healthcare
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Fisher & Paykel Healthcare Limited
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Compumedics Limited
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Developments
    • 8.6. Becton, Dickinson and Company
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Developments
    • 8.7. Breas Medical
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Developments
    • 8.8. AirSep Corporation
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Developments
    • 8.9. Inogen
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Developments
    • 8.10. Invacare Corporation
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product Portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Developments
    • 8.11. Koninklijke Philips N.V.
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Product Portfolio
      • 8.11.4. Business Strategy
      • 8.11.5. Recent Developments
    • 8.12. ResMed
    • 8.12.1. Overview
    • 8.12.2. Financials
    • 8.12.3. Product Portfolio
    • 8.12.4. Business Strategy
    • 8.12.5. Recent Developments
    • 8.13. Medtronic
      • 8.13.1. Overview
      • 8.13.2. Financials
      • 8.13.3. Product Portfolio
      • 8.13.4. Business Strategy
      • 8.13.5. Recent Developments
    • 8.14. Teleflex Incorporated
      • 8.14.1. Overview
      • 8.14.2. Financials
      • 8.14.3. Product Portfolio
      • 8.14.4. Business Strategy
      • 8.14.5. Recent Developments
    • 8.15. Smiths Medical
      • 8.15.1. Overview
      • 8.15.2. Financials
      • 8.15.3. Product Portfolio
      • 8.15.4. Business Strategy
      • 8.15.5. Recent Developments

Methodology

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social